1. Home
  2. Browse
  3. HRA000968
HRA000968
   HRA000968.xlsx
Title:
Strategy for NK cell activation by epigentic compound screening
Release date:
2021-12-06
Description:
Primary human NK cells were treated with DMSO or Daphnetin in the presence of IL-12 (10 ng/ml) for 12 hours.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA005273
Study type:
Medical
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC000542
DAC name:
HRA001286
Contact person:
Deng Youcai
Email:
youcai.deng@tmmu.edu.cn
Description:
Strategy for NK cell activation by epigentic compound screening
Individuals & samples
Files
Request Data
Submitter:   Deng Youcai / youcai.deng@tmmu.edu.cn
Organization:   Army Medical University (Third Military Medical University)
Submission date:   2021-06-22
Requests:   -